Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway
Dong Ren(Sun Yat-sen University), Xinsheng Peng(Sun Yat-sen University)
Cited by 242
Related Papers
Wnt5a induces and maintains prostate cancer cells dormancy in bone
|The Journal of Experimental Medicine|2018|223
Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
|Oncotarget|2017|168
m<sup>6</sup>A modification of lncRNA <i>PCAT6</i> promotes bone metastasis in prostate cancer through <i>IGF2BP2</i>‐mediated <i>IGF1R</i> mRNA stabilization
|Clinical and Translational Medicine|2021|156
miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells
|Oncology Reports|2012|134
Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145
|International Journal of Oncology|2013|134